Global siRNA Drug Competitive Landscape Professional Research Report 2024

Global siRNA Drug Competitive Landscape Professional Research Report 2024

Research Summary

An siRNA drug, short for small interfering RNA drug, is a type of therapeutic agent that utilizes synthetic RNA molecules to selectively silence the expression of specific disease-causing genes. These drugs are designed to target and inhibit the production of messenger RNA (mRNA) molecules that encode proteins involved in various diseases, ranging from viral infections to genetic disorders and cancer. By harnessing the natural mechanism of RNA interference, siRNA drugs offer a potent and highly specific approach to gene regulation, with the potential to treat a wide range of medical conditions. They are typically administered via various delivery methods, including nanoparticles, to ensure efficient uptake by target cells and achieve therapeutic effects. Ongoing research aims to optimize the design and delivery of siRNA drugs, addressing challenges such as off-target effects and immune response, to enhance their safety and efficacy in clinical applications.

According to DIResearch's in-depth investigation and research, the global siRNA Drug market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.

The major global manufacturers of siRNA Drug include Genzyme, Alnylam, Dicerna, Quark Pharmaceuticals, Arrowhead, Exicure, Miragen Therapeutics, Silence, Sylentis, Avidity Biosciences, Dicerna, BioNTech, Moderna Therapeutics, The WhiteOak Group, Inc. etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of siRNA Drug. Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global siRNA Drug market. The report data covers historical data from 2019 to 2023, based year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the siRNA Drug market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of siRNA Drug industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.    

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of siRNA Drug Include:

Genzyme

Alnylam

Dicerna

Quark Pharmaceuticals

Arrowhead

Exicure

Miragen Therapeutics

Silence

Sylentis

Avidity Biosciences

Dicerna

BioNTech

Moderna Therapeutics

The WhiteOak Group, Inc.

siRNA Drug Product Segment Include:

Givlaari

Patisiran

Givosiran

siRNA Drug Product Application Include:

Single Gene Rare Disease

Protein Deposition Disease

Chronic Liver Disease

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global siRNA Drug Industry PESTEL Analysis

Chapter 3: Global siRNA Drug Industry Porter’s Five Forces Analysis

Chapter 4: Global siRNA Drug Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 5: Global siRNA Drug Market Size and Forecast by Type and Application Analysis

Chapter 6: North America siRNA Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe siRNA Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China siRNA Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) siRNA Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America siRNA Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa siRNA Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global siRNA Drug Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources